Cardiovascular Intervention and Therapeutics最新文献_第2页

A "Pure white clot": nonbacterial thrombotic endocarditis as a cause of coronary embolism. “纯白色血块”：非细菌性血栓性心内膜炎是冠状动脉栓塞的原因。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2025-01-05 DOI: 10.1007/s12928-024-01082-6

Kosuke Hayashi, Masashi Yokoi, Sayuri Yamabe, Tsuyoshi Ito, Hideo Hattori, Yoshihiro Seo

引用次数: 0

Effect of balloon pulmonary angioplasty on chronic thromboembolic pulmonary hypertension: an assessment of the learning curve in a Japanese university hospital. 球囊肺动脉成形术治疗慢性血栓栓塞性肺动脉高压的效果：日本大学医院的学习曲线评估。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-12-30 DOI: 10.1007/s12928-024-01076-4

Naohiro Komura, Teruyasu Sugano, Fumiaki Ono, Mina Nakayama, Toru Suzuki, Noriyuki Kawaura, Junya Hosoda, Masaaki Konishi, Noriaki Iwahashi, Tomoaki Ishigami, Makoto Mo, Kiyoshi Hibi

{"title":"Effect of balloon pulmonary angioplasty on chronic thromboembolic pulmonary hypertension: an assessment of the learning curve in a Japanese university hospital.","authors":"Naohiro Komura, Teruyasu Sugano, Fumiaki Ono, Mina Nakayama, Toru Suzuki, Noriyuki Kawaura, Junya Hosoda, Masaaki Konishi, Noriaki Iwahashi, Tomoaki Ishigami, Makoto Mo, Kiyoshi Hibi","doi":"10.1007/s12928-024-01076-4","DOIUrl":"10.1007/s12928-024-01076-4","url":null,"abstract":"Balloon pulmonary angioplasty (BPA) is an innovative treatment for chronic thromboembolic pulmonary hypertension (CTEPH). We retrospectively examined the clinical outcomes and complications of BPA at Yokohama City University Hospital (YCUH) between 2012 and 2018. In 2012, we began to conduct BPA sessions in 46 patients with inoperable CTEPH; 34 completed the BPA scheme and the follow-up plan. A longitudinal sub-analysis was performed with cohorts 1 and 2 receiving BPA before and after April 2015. Significant improvements in the mean pulmonary arterial pressure, pulmonary vascular resistance, and other parameters were detected after BPA. The total rate of thoracic complications was 25%. Specifically, the increase in SaO2 and home oxygen therapy discontinuation rate, and oral riociguat discontinuation rate was significantly higher in cohort 2 (+ 7.7, 75, and 59%) compared to cohort 1 (+ 3.1, 27, and 10%) (P < 0.05). Moreover, the need for non-invasive positive pressure ventilation was significantly lower: 0% (cohort 2) vs. 7% (cohort 1) (P < 0.05). The BPA sessions conducted at the YCUH resulted in significant improvements in patients with CTEPH. This study demonstrates a clear learning curve regarding the effectiveness of BPA both in normalizing SaO2 and facilitating the cessation of home oxygen therapy, as well as in reducing the incidence of severe complications.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"389-399"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Expert consensus statement for quantitative measurement and morphologic assessment of optical coherence tomography: update 2025.

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2025-01-28 DOI: 10.1007/s12928-024-01080-8

Kenichi Fujii, Takashi Kubo, Hiromasa Otake, Gaku Nakazawa, Shinjo Sonoda, Kiyoshi Hibi, Toshiro Shinke, Yoshio Kobayashi, Yuji Ikari, Ken Kozuma, Takashi Akasaka

引用次数: 0

A novel hemostatic method for Impella removal using a shortened Perclose Proglide™ device under proximal balloon occlusion. 在近端球囊闭塞的情况下，使用缩短的 Perclose Proglide™ 装置拔除 Impella 的新型止血方法。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-12-13 DOI: 10.1007/s12928-024-01072-8

Yumika Tsuji, Masao Takigami, Shunta Taminishi, Makoto Saburi, Yoshinori Tsubakimoto, Jun Shiraishi

引用次数: 0

Coil Embolization for Pulmonary Artery Rupture into the Pleural Cavity during Balloon Pulmonary Angioplasty. 球囊肺血管成形术中肺动脉破裂进入胸腔的线圈栓塞治疗。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2025-01-13 DOI: 10.1007/s12928-024-01083-5

Makiko Matsuike, Ryosuke Ito, Jun Yamashita, Kazuhiro Satomi

引用次数: 0

Detection and nanagement of stent under-expansion in self-expanding TAVR using a steep right anterior oblique view. 自扩张TAVR中支架扩张不足的检测与处理。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-12-19 DOI: 10.1007/s12928-024-01078-2

Umihiko Kaneko, Daisuke Hachinohe, Ryo Horita, Ryo Otake, Kazuki Mizutani, Ken Kobayashi

引用次数: 0

Feasibility of combined therapy: percutaneous left atrial appendage closure and transcatheter edge-to-edge repair. 联合疗法的可行性：经皮左心房阑尾闭合术和经导管边缘到边缘修补术。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-11-28 DOI: 10.1007/s12928-024-01065-7

Nobuyuki Fukuda, Teruhiko Imamura, Shuhei Tanaka, Naoya Kataoka, Ryuichi Ushijima, Hiroshi Ueno, Koichiro Kinugawa

{"title":"Feasibility of combined therapy: percutaneous left atrial appendage closure and transcatheter edge-to-edge repair.","authors":"Nobuyuki Fukuda, Teruhiko Imamura, Shuhei Tanaka, Naoya Kataoka, Ryuichi Ushijima, Hiroshi Ueno, Koichiro Kinugawa","doi":"10.1007/s12928-024-01065-7","DOIUrl":"10.1007/s12928-024-01065-7","url":null,"abstract":"Patients with atrial fibrillation (AF) often present with concomitant significant mitral regurgitation (MR). Percutaneous left atrial appendage closure (LAAC) is indicated for patients with AF to prevent thromboembolism and reduce the need for long-term anticoagulation. Transcatheter edge-to-edge repair (TEER) is recommended for patients with significant MR. However, the feasibility and efficacy of combining these therapeutic interventions remain uncertain. This study included consecutive patients who underwent LAAC. Feasibility was assessed by comparing outcomes between those undergoing combined LAAC + TEER and those receiving LAAC alone. Among 192 patients, 11 underwent the combined LAAC + TEER procedure, while 181 underwent LAAC alone. Procedural success was high in both groups (100% vs. 99%). At the 1-year follow-up, the incidence of significant device leak and device-related thrombus did not differ significantly between the groups (0% vs. 1.1% and 0% vs. 6.7%, respectively; p > 0.05 for both). Additionally, the cumulative incidence of thromboembolic and bleeding events was comparable between the two groups (thromboembolic p = 0.57 and bleeding p = 0.42). The combination of LAAC + TEER may be a feasible and effective therapeutic strategy when performed in carefully selected patients at high-volume, experienced centers.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"400-413"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparison of clinical outcomes between direct and indirect transfer in patients with ST-segment elevation myocardial infarction. st段抬高型心肌梗死直接与间接转移治疗的临床效果比较。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-12-11 DOI: 10.1007/s12928-024-01075-5

Yoshiaki Hai, Kenichi Sakakura, Hiroyuki Jinnouchi, Yousuke Taniguchi, Kei Yamamoto, Takunori Tsukui, Masashi Hatori, Taku Kasahara, Yusuke Watanabe, Shun Ishibashi, Masaru Seguchi, Hideo Fujita

{"title":"Comparison of clinical outcomes between direct and indirect transfer in patients with ST-segment elevation myocardial infarction.","authors":"Yoshiaki Hai, Kenichi Sakakura, Hiroyuki Jinnouchi, Yousuke Taniguchi, Kei Yamamoto, Takunori Tsukui, Masashi Hatori, Taku Kasahara, Yusuke Watanabe, Shun Ishibashi, Masaru Seguchi, Hideo Fujita","doi":"10.1007/s12928-024-01075-5","DOIUrl":"10.1007/s12928-024-01075-5","url":null,"abstract":"Primary percutaneous coronary intervention (PCI) is the cornerstone of treatment for ST-segment elevation myocardial infarction (STEMI). Previous studies suggest that direct transport by ambulance to a primary PCI facility is associated with better clinical outcomes in patients with STEMI. However, those studies included seriously ill patients for whom direct transport is the only option. We included 462 patients with STEMI who were supposed to select either direct transport by ambulance or indirect transport via primary care doctor, and compared the clinical outcomes between the direct transfer group (n = 172) and the indirect transfer group (n = 290). The primary endpoint was major adverse cardiovascular events (MACE), which was defined as the composite of all-cause death, non-fatal myocardial infarction, re-admission for heart failure, and target vessel revascularization. The median follow-up duration was 540 days (86-1266 days). Age was significantly higher in the indirect transfer group [72.0 (64-80) years] than in the direct transfer group [69.5 (58.3-77) years] (p = 0.013). Onset to balloon time was significantly shorter in the direct transport group (p < 0.001). The Kaplan-Meier curves revealed that MACE were similarly observed between the two groups (31.4% vs. 27.2%; p = 0.330). After adjusting for potential confounders, indirect transfer was not associated with MACE (adjusted hazard ratio: 0.740, 95% confidence interval: 0.485-1.128, p = 0.161). In conclusion, indirect transfer was not associated with poor clinical outcomes in patients with STEMI who were supposed to select either direct transport or indirect transport.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"277-286"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142805793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of intravascular ultrasound on limb events in endovascular therapy for patients with peripheral arterial disease: insights from the TOMA-CODE registry. 血管内超声对外周动脉疾病患者血管内治疗中肢体事件的影响：来自TOMA-CODE注册的见解

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-12-27 DOI: 10.1007/s12928-024-01079-1

Takahide Kodama, Masanari Kuwabara, Daisuke Ueshima, Tetsuo Yamaguchi, Yo Fujimoto, Toru Miyazaki, Atsushi Mizuno, Kenji Suzuki, Hitoshi Anzai, Michiaki Higashitani

{"title":"Impact of intravascular ultrasound on limb events in endovascular therapy for patients with peripheral arterial disease: insights from the TOMA-CODE registry.","authors":"Takahide Kodama, Masanari Kuwabara, Daisuke Ueshima, Tetsuo Yamaguchi, Yo Fujimoto, Toru Miyazaki, Atsushi Mizuno, Kenji Suzuki, Hitoshi Anzai, Michiaki Higashitani","doi":"10.1007/s12928-024-01079-1","DOIUrl":"10.1007/s12928-024-01079-1","url":null,"abstract":"Intravascular ultrasound (IVUS) has become a standard procedure for performing coronary intervention, but its impact on peripheral endovascular therapy (EVT) remains unclear. To assess the usefulness of IVUS during EVT, this study analyzed over 2000 consecutive patients from the TOkyo-taMA peripheral vascular intervention research COmraDE (TOMA-CODE) registry with peripheral arterial disease (PAD) in Japan. The primary outcome was chronic limb events (a composite of clinically driven target lesion revascularization (cTLR) and major amputation) during a two-year follow-up period. The secondary outcomes included the procedural success rate, in-hospital major adverse limb events (MALE), and major cardiac and cerebrovascular events (MACCE). Patients with and without IVUS were compared using propensity score matching. Among the 2227 eligible cases enrolled, with a median follow-up period of 10.4 months, there were no significant differences in limb events between IVUS (784 patients) and non-IVUS (1443 patients) groups during the follow-up period (15.4% vs. 14.4%, P = 0.53, unadjusted; 14.8% vs. 15.4%, P = 0.77, adjusted). In contrast, the IVUS group had higher procedural success rates (98.7% vs. 96.7%, P = 0.02) and lower in-hospital MALE (1.6% vs. 4.1%, P = 0.01), even after multiple adjustments. Additionally, there was no significant difference in the MACCE incidence (10.9% vs. 12.2%, P = 0.47) between the groups. This study demonstrated that IVUS usage did not reduce the occurrence of limb events among EVT patients in the chronic phase, but IVUS may improve in-hospital outcomes. Further research is necessary to verify these findings.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"344-351"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

CVIT 2025 clinical expert consensus document on intravascular ultrasound.

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2025-01-27 DOI: 10.1007/s12928-025-01090-0

Yuichi Saito, Yoshio Kobayashi, Kenichi Fujii, Shinjo Sonoda, Kenichi Tsujita, Kiyoshi Hibi, Yoshihiro Morino, Hiroyuki Okura, Yuji Ikari, Ken Kozuma, Junko Honye

引用次数: 0